| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy, 1-382, 2021 | 9377* | 2021 |
| Mir-34: a new weapon against cancer? G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ... Molecular therapy-nucleic acids 3, e195, 2014 | 442 | 2014 |
| Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in … D Santini, B Vincenzi, S Galluzzo, F Battistoni, L Rocci, O Venditti, ... Clinical Cancer Research 13 (15), 4482-4486, 2007 | 405 | 2007 |
| Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview M Marra, IM Sordelli, A Lombardi, M Lamberti, L Tarantino, A Giudice, ... Journal of translational medicine 9 (1), 1-14, 2011 | 217 | 2011 |
| Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ... Clinical cancer research 18 (22), 6260-6270, 2012 | 209 | 2012 |
| Familial papillary thyroid microcarcinoma: a new clinical entity G Lupoli, G Vitale, M Caraglia, MR Fittipaldi, A Abbruzzese, P Tagliaferri, ... The Lancet 353 (9153), 637-639, 1999 | 204 | 1999 |
| Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism M Donadelli, I Dando, T Zaniboni, C Costanzo, E Dalla Pozza, MT Scupoli, ... Cell death & disease 2 (4), e152-e152, 2011 | 196 | 2011 |
| Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib B Vincenzi, D Santini, A Russo, R Addeo, F Giuliani, L Montella, S Rizzo, ... The oncologist 15 (1), 85, 2010 | 187 | 2010 |
| Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, ... British journal of cancer 88 (12), 1971-1978, 2003 | 186 | 2003 |
| The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis A Lamberti, M Caraglia, O Longo, M Marra, A Abbruzzese, P Arcari Amino acids 26 (4), 443-448, 2004 | 183 | 2004 |
| Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in … E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ... Journal of cellular physiology 195 (1), 139-150, 2003 | 171 | 2003 |
| miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ... Journal of cellular physiology 228 (7), 1506-1515, 2013 | 169 | 2013 |
| Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007 | 159 | 2007 |
| miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ... Cell death & disease 3 (11), e436-e436, 2012 | 157 | 2012 |
| Emerging anti-cancer molecular mechanisms of aminobisphosphonates M Caraglia, D Santini, M Marra, B Vincenzi, G Tonini, A Budillon Endocrine-related cancer 13 (1), 7-26, 2006 | 154 | 2006 |
| Alpha‐interferon and its effects on signal transduction pathways M Caraglia, M Marra, G Pelaia, R Maselli, M Caputi, SA Marsico, ... Journal of cellular physiology 202 (2), 323-335, 2005 | 151 | 2005 |
| Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells M Caraglia, M Marra, F Mancinelli, G D'ambrosio, R Massa, A Giordano, ... Journal of cellular physiology 204 (2), 539-548, 2005 | 150 | 2005 |
| DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ... Oncotarget 3 (10), 1246, 2012 | 144 | 2012 |
| HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT F Bruzzese, A Leone, M Rocco, C Carbone, G Piro, M Caraglia, ... Journal of cellular physiology 226 (9), 2378-2390, 2011 | 133 | 2011 |
| Current approaches and perspectives in the therapy of medullary thyroid carcinoma G Vitale, M Caraglia, A Ciccarelli, G Lupoli, A Abbruzzese, P Tagliaferri, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 133 | 2001 |
Pierosandro Tagliaferriprofessore di oncologia medica Università magna graecia di CatanzaroVerified email at unicz.it
